Palivizumab
Products in Health Canada’s databases that list Palivizumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 4
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| SYNAGIS (100 MG) | 02438364 | Dormant | Astrazeneca Canada Inc | |
| SYNAGIS (50 MG) | 02438372 | Dormant | Astrazeneca Canada Inc | |
| SYNAGIS (50 MG) | 02245889 | Cancelled Post Market | AbbVie Corporation | |
| SYNAGIS (100 MG) | 02245890 | Cancelled Post Market | AbbVie Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- SYNAGISJuly 9, 2021 · NOC 26262
- SYNAGISMay 6, 2021 · NOC 25817
- SYNAGISApril 9, 2018 · NOC 20713
- SYNAGISMarch 6, 2015 · NOC 16658
- SYNAGISOctober 21, 2014 · NOC 16201
- SYNAGISNovember 23, 2012 · NOC 13885
- SYNAGISJune 30, 2008 · NOC 9645
- SYNAGISApril 11, 2006 · NOC 7877
- SYNAGISFebruary 16, 2005 · NOC 6281
- SYNAGISMay 15, 2002 · NOC 763